Tenet Healthcare Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
Portfolio Pulse from Benzinga Insights
In the last three months, 13 analysts have published ratings on Tenet Healthcare (NYSE:THC), with a mix of bullish and somewhat bullish perspectives. The average 12-month price target has increased by 15.38% to $135.0. Analysts have raised their price targets, reflecting positive sentiment towards the company's financial performance, including a 6.91% revenue growth rate and strong financial health indicators.
July 02, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown a predominantly bullish sentiment towards Tenet Healthcare (NYSE:THC) over the last three months, with the average 12-month price target increasing by 15.38% to $135.0. The company's strong financial performance, including a 6.91% revenue growth rate and high net margin, ROE, and ROA, has contributed to this positive outlook.
The increase in the average 12-month price target and the predominantly bullish sentiment from analysts indicate a positive short-term impact on Tenet Healthcare's stock price. The company's strong financial performance, including revenue growth and high financial health indicators, supports this optimistic outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100